Resources for Food and Drug Administration (FDA)

2 heartburn drugs seem OK for heart, says FDA

seattletimes.nwsource.com

Federal regulators Thursday said they have opened a safety investigation of two popular heartburn drugs Nexium, marketed as the "purple pill," and Prilosec, its older chemical cousin — after receiving clinical data that appeared to link them to serious heart problems.

But the Food and Drug Administration emphasized that it has found no firm evidence of such a connection, and it advised doctors and patients not to make any changes in medication practices. The agency promised a more complete answer within three months.

"At this time, FDA's preliminary conclusion is that collectively these data do not suggest an increased risk of heart problems," according to an agency statement. "Therefore, FDA does not believe that health-care providers or patients should change either their prescribing practices or their use of these products at this time."

View the Resource

Share or bookmarklet this web page at: